Danielle R. Mercatante, Ph.D.

Affiliations: 
2002 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacology, Oncology, Cell Biology
Google:
"Danielle Mercatante"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Ryszard Kole grad student 2002 UNC Chapel Hill
 (Modification of the alternative splicing patterns of Bcl-x pre -mRNA: Induction of cell death and chemosensitization of cancer cells.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bristow CL, Mercatante DR, Kole R. (2003) HIV-1 preferentially binds receptors copatched with cell-surface elastase. Blood. 102: 4479-86
Ghio AJ, Nozik-Grayck E, Turi J, et al. (2003) Superoxide-dependent iron uptake: a new role for anion exchange protein 2. American Journal of Respiratory Cell and Molecular Biology. 29: 653-60
Mercatante DR, Mohler JL, Kole R. (2002) Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. The Journal of Biological Chemistry. 277: 49374-82
Mercatante DR, Kole R. (2002) Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochimica Et Biophysica Acta. 1587: 126-32
Mercatante DR, Sazani P, Kole R. (2001) Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases. Current Cancer Drug Targets. 1: 211-30
Mercatante DR, Bortner CD, Cidlowski JA, et al. (2001) Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. The Journal of Biological Chemistry. 276: 16411-7
Gorman L, Mercatante DR, Kole R. (2000) Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. The Journal of Biological Chemistry. 275: 35914-9
Mercatante D, Kole R. (2000) Modification of alternative splicing pathways as a potential approach to chemotherapy Pharmacology and Therapeutics. 85: 237-243
See more...